| Name | Title | Contact Details |
|---|
Nice-Pak, founded in 1955 and headquartered in Orangeburg, NY is the largest global producer of pre-moistened wipes, including brands such as the original Wet-Nap® Moist Towelletes, Sani-Hands® Instant Hand Sanitizing Wipes, and Sani-Cloth® Germicidal Disposable Wipes. The company pioneered the development of pre-moistened wipes as the optimum dispensing system for cleaning, sanitization and disinfecting in healthcare, household, cosmetic and personal hygiene applications. Nice-Pak/PDI leverages state-of-the-art product development and manufacturing capabilities to supply superior, leading-edge products to every class of trade.
Hoewisch Chiropractic Office is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Henry Schein Practice Solutions is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clearly is the largest online eyewear company in the world with a mission to make vision correction accessible worldwide. Founded in 2000, Clearly's family of websites offers the most extensive selection of contact lenses, eyeglasses and sunglasses shipped directly to your door. Through Clearly’s Change the View Project, every purchase helps fight poor vision by providing access to tailored eye health solutions on a global scale. Owned by Essilor, Clearly is headquartered in Vancouver, B.C.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally. Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla`s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001. Cipla`s research and development focuses on developing innovative products and drug delivery systems.